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The retinal circulation is regulated by different local factors and might include the retinal
relaxing factor (RRF). This factor is found to be continuously released by the retina and
relaxes smooth muscle cells. This review describes the current knowledge about the RRF.
Despite many research efforts, the cellular source, identity, mechanism, and physiological role
of the RRF remain largely unknown. Thus far, it seems that the RRF is a hydrophilic,
thermostable, diffusible chemical messenger, which characteristics do not correspond with
most well-known endogenous vasorelaxants. The RRF-induced relaxation seems to rely on
activation of the inward rectifier Kþ channels and the Rho kinase Ca2þ sensitization
mechanism. Voltage-dependent Kþ channels and plasma membrane Ca2þ-ATPase might also
be involved, whereas the involvement of cyclooxygenase is still a point of discussion.
Furthermore, it appears that the RRF is involved in other relaxation pathways, namely those
of hypoxia, adenosine, and adenosine triphosphate, hydrogen sulfide, c-aminobutyric acid,
and dorzolamide.
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The retina is a layer of the eye with an important role invision as it converts the incoming light into a neuronal
signal. The high demands of oxygen and metabolic substrates
require that the blood flow can be regulated to maintain the
retinal structure and function. The retina is vascularized by two
blood circulations, the choroidal and retinal circulation, with
different functional and anatomical characteristics. The choroi-
dal circulation has a superfluous blood flow and is regulated by
the autonomic nervous system. The retinal circulation lacks
adrenergic, cholinergic, or peptidergic innervation and is
mainly regulated by autoregulatory mechanisms and local
paracrine factors, such as nitric oxide (NO) and prostaglan-
dins.1–3
In 1998, a new paracrine factor was discovered during
experiments on isolated retinal arteries. A huge variation in
contractile response to prostaglandin F2a (PGF2a) was observed
in a study on isolated bovine retinal arteries. Because damage of
smooth muscle cells of the arteries during the isolation was
thought to be the reason for this variation, efforts were made to
reduce damage by cleaning them not too rigorously from
adherent tissue. Surprisingly, the arteries then no longer
contracted to PGF2a. In further experiments, it was found that
the contraction level of bovine retinal arteries with adhering
retinal tissue was significantly lower than of those completely
cleaned of adhering retinal tissue. Similar results were obtained
when contracting the bovine retinal arteries with other
contractile substances than PGF2a, such as serotonin, endothe-
lin-1, or the thromboxane A2 mimetic U-46619. One explana-
tion for this observation could be that the retina, like the
endothelium releases NO, continuously releases a relaxing
factor. To test this hypothesis, a bioassay was set up in which a
bovine retinal artery was mounted for isometric tension
measurements and contracted with PGF2a. Once the contrac-
tion was stabilized, a piece of bovine retina was brought in
proximity of the bovine retinal artery. This elicited a rapid,
complete, and stable relaxation. When the retina was removed,
the relaxing influence completely disappeared. The relaxing
influence of retinal tissue could be reproduced using retinal
tissue of pigs, dogs, and sheep.4 A relaxing effect was not seen
when bringing bovine choroid tissue in proximity of the bovine
retinal artery, illustrating the tissue specificity. On the other
hand, retinal tissue also relaxes nonretinal arteries, such as rat
renal and mesenteric arteries, and even nonvascular smooth
muscle preparations, such as rat main bronchi. This more
general relaxing factor was coined the name retinal relaxing
factor (RRF).4
In the years following these initial observations, a lot of
effort was made to reveal the secrets of the RRF. Several studies
by different research groups have tried to find out the identity
of RRF and the mechanism of the RRF-induced relaxation.
However, until now, these questions remain largely unan-
swered. This review aims to overview the actual knowledge
about the RRF.
IDENTITY OF THE RRF
One of the first steps in the effort to discover the identity of the
RRF was to incubate a bovine retina in a physiologic solution
and to test then whether this solution could elicit a
vasorelaxation. This solution could indeed induce vasorelax-
ation.4 Similar results were obtained by Lee et al. using rat
retinas.5 These experiments prove that the RRF is a diffusible
and stable chemical messenger. Hexane extraction, heating the
solution up to 708C or treatment with trypsin did not change
the vasorelaxing effect of the RRF, suggesting that the RRF is
hydrophilic, thermostable, and not a polypeptide or protein.4
Further research concentrated on the possibility that the
RRF might be identified as NO, cyclooxygenase (COX)
metabolites, or other known vasorelaxants formed in the
retina. Based on the characteristics, some molecules could
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already be excluded from being the RRF. NO can be excluded,
because it is not a thermostable molecule. This finding is
confirmed by the observation that Nx-Nitro-L-arginine (L-NA), a
blocker of NO synthase, does not reduce the relaxation.4,6,7
The RRF response was also observed in neuronal NO synthase
(nNOS) knockout mice.7 Also, the observation that NO as such
has a much smaller relaxing influence than the RRF excludes
NO as being the RRF.8
Whether the RRF is a COX product or not is unclear. In
bovine retina indomethacin, a COX inhibitor did not reduce
the RRF effect, proving that COX products are not involved.
This was confirmed on bovine, rat, and mice retina by using
the COX inhibitors indomethacin and sodium diclofenac.4,6,7
However, on porcine tissues, the RRF-induced relaxation was
found to be completely blocked by ibuprofen, another COX
inhibitor.9 Epoxyeicosatrienoic acid (EET) could be excluded
from being the RRF, because blocking EET synthase with the
inhibitors SKF-525A and miconazole had no effect.5
The vasorelaxing capacity of different vasorelaxants, known
to be released in the retina, were tested on bovine retinal
arteries to see whether the RRF corresponded with one of
them. Glutamate, glycine, c-aminobutyric acid (GABA), mela-
tonin, and dopamine all failed to relax the retinal arteries.4 Also
aspartic acid and taurine failed to relax rat carotid arteries in
contrast to the RRF.6 L-Lactate was able to relax retinal arteries,
but the concentration needed for this relaxation was much
higher than usually present in the retina.10 In addition, the
relaxation induced by L-lactate is NO dependent, whereas the
RRF-induced relaxation is not.11,12 Acetylcholine, histamine,
and other endothelium-dependent vasodilators could also be
excluded, because the RRF relaxation is endothelium indepen-
dent. Adenosine did relax bovine retinal arteries,2,4 but the
adenosine receptor blocker 8-phenyltheophylline could not
reduce the RRF relaxation. In addition, adenosine could not
relax rat main bronchi, whereas the RRF did.4
Also, adrenomedullin was excluded. Adrenomedullin relax-
es bovine retinal arteries via an endothelium-dependent
mechanism and is inhibited by calcitonin gene-related peptide
(CGRP) 8-37, an antagonist of the CGRP1 receptor. However,
the vasorelaxing mechanism of the RRF is not endothelium
dependent and is not inhibited by CGRP 8-37.13 Also CGRP
was studied because it relaxes bovine retinal arteries.
However, its mechanism is endothelial NO dependent, in
contrast to the RRF. Natriuretic peptides ANP (atrial), BNP
(brain), and CNP (C-type) have also been tested, but they were
not able to elicit a substantial relaxation.14 It is also unlikely
that proteins, such as vasoactive intestinal peptide, substance
P, or somatostatin, are the RRF, because the RRF is not
destroyed by trypsin.4
In 2010, Lee et al.5 reported evidence that the RRF might be
identified as methyl palmitate. This was based on analysis by
gas chromatography/mass spectrometry of a RRF-containing
solution, obtained by incubation of rat retina. Further evidence
was derived from the fact that the release of the RRF and
methyl palmitate are both calcium-dependent, that their
relaxations rely on activation of voltage-dependent potassium
(KV) channels, and that their relaxations remain after being
heated for 1 hour at 708C.5 Furthermore, extraction with
hexane reduces the relaxing effect of the RRF and methyl
palmitate to the same degree. This result is in contrast to the
findings of Delaey et al., who found that the RRF relaxation was
similar after hexane extraction.4 As yet, the identification of the
RRF as methyl palmitate has not been confirmed by other
research groups. In contrast, Takir et al. could not detect a
relaxing effect of methyl palmitate on bovine retinal arteries.15
Also, we were unable to confirm that methyl palmitate relaxes
arteries and can be identified as the RRF (unpublished
observations). Thus, the identity of the RRF remains unknown,
which probably means that the right suspect has not been
investigated yet. However, the possibility that the right one has
been excluded wrongly should also be kept in mind. An
overview of what is known about the identity of the RRF thus
far is summarized in the Table.
MECHANISMS MEDIATING THE RRF-INDUCED
RELAXATION
Adhering retinal tissue causes reduced contraction of arteries,
and when a piece of retina is placed on top of an artery, a
relaxation is seen. The percentage relaxation depends on the
species and arteries being used. When a bovine retina is placed
on a bovine retinal artery a complete relaxation is caused.
Placing a rat retina on a rat carotid artery causes 33.24%
relaxation and mouse retina on a mouse aorta 21.57%
relaxation. All relaxations in these studies seem to be
monophasic.4,6,7 In the study of Takir et al., the relaxation
seen by placing a bovine retina on a bovine retinal artery is
biphasic, suggesting that there are two mechanisms or factors
involved.15
One of the first mechanisms to be tested was the
involvement of the endothelium. Removal of the endothelium
did not change the effect of the RRF on bovine retinal
arteries.4,15 This finding was confirmed for the rat RRF.6,15
There is evidence that NO synthase (NOS) and COX are not
involved in the RRF-induced relaxation. However, Holmgaard
et al. suggested the involvement of a COX product, because
inhibition of COX blocked the RRF-induced relaxation com-
pletely.9 Cyclic guanosine monophosphate (cGMP) seems not
to be involved in the RRF-induced relaxation, because no
differences in the RRF-induced relaxation were seen by using
methylene blue, a blocker of guanylyl cyclase.4 1H-[1,2,4]ox-
adiazolo-[4, 3-a]quinoxalin-1-one (ODQ), a soluble guanylyl
cyclase (sGC) blocker, also had no effect. This is in accordance
TABLE. Overview of the Knowledge About the Identity of the RRF
Excluded Molecules Characteristics
Nitric oxide (confirmed on bovine, rat and mice retina)
Cyclooxygenase products (confirmed on bovine, rat and mice retina, but not on
porcine retina)
Epoxyeicosatrienoic acids (confirmed on rat retina)
Glutamate, glycine, GABA, melatonin, dopamine, L-lactate, adenosine,
adrenomedulline, calcitonin gene-related peptide, natriuretic peptides ANP, BNP, and
CNP (confirmed on bovine retina)
Acetylcholine, histamine or other endothelium-dependent vasodilators (confirmed on
bovine retina)
Aspartic acid and taurine (confirmed on rat retina)
Diffusible, stable chemical messenger (confirmed
on bovine and rat retina)
Hydrophilic (confirmed on bovine retina, but not
on rat retina)
Thermostable (confirmed on bovine and rat
retina)
Resistant to trypsin (confirmed on bovine retina)
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with the observation that NO donors, which activate sGC,
elicit only a small relaxing effect on bovine retinal arteries.6–8
Furthermore, the RRF response is still present in sGCa1-
knockout mice, whereas sGCa1 is the most important isoform
of sGC present in vascular smooth muscle.2 Also cAMP is
probably not involved, because its levels were not elevated in
rat arteries that were relaxed by the RRF.2 Holmgaard et al.
demonstrated that the RRF-induced relaxation is reduced by DL-
amino-5-phosphonovaleric acid, an N-methyl-D-aspartate
(NMDA) receptor antagonist, suggesting the involvement of
NMDA receptors.9
The Ca2þ-lowering mechanisms leading to smooth muscle
relaxation were also studied. Blockade of sarco/endoplasmic
reticulum Ca2þ ATPase (SERCA) with thapsigargin and cyclo-
piazonic acid did not influence the RRF-induced relaxation.6,16
Also, blocking the Naþ-Ca2þ exchanger with dimethyl-2-
thiourea (DMTU) or amiloride had no influence.6 L-type Ca2þ
channels are also not involved, because blocking them with
nifedipine did not change the RRF relaxation.16 Surprisingly,
blocking the plasma membrane Ca2þ-adenosine triphosphate
(ATP)ase (PMCA) with vanadate inhibited the RRF-induced
relaxation (Fig. 1). However, it should be noted that vanadate is
not a specific blocker of PMCA, so the conclusion that PMCA is
involved in the RRF-induced relaxation requires further
investigation.6
Besides Ca2þ-lowering mechanisms, a Ca2þ sensitization
mechanism could be involved in the relaxation caused by the
RRF. Inhibition of myosin light chain phosphatase by calyculin
A abolished the RRF-induced relaxation completely. There are
two important Ca2þ sensitization pathways: one via Rho kinase
and one via protein kinase C (PKC). Calphostin C, a PKC
inhibitor, induced only a weak relaxation in PGF2a or 120 mM
Kþ Krebs-Ringer bicarbonate (KRB) contracted arteries, indi-
cating that the RRF does not act via PKC. On the other hand, Y-
27632, a Rho kinase inhibitor, induced a complete relaxation in
PGF2a-contracted arteries and a moderate relaxation in 120 mM
Kþ KRB-contracted arteries. This difference in the vasorelaxing
effect of Y-27632 is comparable to the vasorelaxing effect of
the RRF, indicating that the RRF might interfere with Rho
kinase (Fig. 1). Interestingly, the retinal adhering tissue
together with Y-27632 can cause an almost complete relaxation
in 120 mM Kþ KRB-contracted arteries.16
Potassium (Kþ) channels could be involved in the RRF
relaxation, because bovine retinal arteries relax less when
contracted with a 120 mM Kþ KRB solution.4 It even changes
the biphasic RRF-induced relaxation into a monophasic one.15
Lee et al. tested different Kþ channels inhibitors and observed
that blocking voltage-dependent Kþ (KV) channels with 4-
aminopyridine (4-AP) inhibited the RRF-induced relaxation on
rat aortas (Fig. 1). A more general Kþ channel blocker,
tetraethylammonium (TEA), did the same.5 However, Takir et
al. could not confirm these observations for bovine RRF,
because 4-AP and TEA were unable to block the RRF-induced
relaxation.15 The contradictory results about the involvement
of KV channels could be attributed to the use of different
contractile substances (phenylephrine versus PGF2a) and
different species or arteries (rat aorta versus bovine retinal
artery).15 Both studies also tested ATP-sensitive Kþ (KATP)
channels with the blocker glibenclamide and concluded that it
had no effect. Calcium-actived Kþ (KCa) channels were tested
by using iberiotoxin on rat retina and charybdotoxin (big and
intermediate KCa blocker) and apamin (small KCa blocker) on
bovine retina. All these blockers did not reduce the RRF-
induced relaxation. However, inward rectifier Kþ (Kir) channels
seem to be involved (Fig. 1). Their inhibition with barium
chloride (BaCl2) reduced the RRF-induced relaxation and
changed the biphasic relaxation in a monophasic one.16
RETINAL RELAXING FACTOR IN HYPOXIA-INDUCED
RELAXATION
Development of several eye diseases, such as glaucoma or
diabetic retinopathy, is associated with an impaired oxygen
supply. Retinal blood vessels contract in response to hyperoxia
and dilate in response to hypoxia. This hypoxic vasodilation
can be regulated by direct effects from the blood vessel wall or
indirect effects from the surrounding tissue.2,17
Winther et al. found that the hypoxia-induced vasorelax-
ation was present in porcine retinal arterioles with and without
adhering retinal tissue.18 Delaey et al. provided evidence that
the hypoxic vasodilation on bovine retinal arteries is largely
regulated by an indirect effect from the retina. The induction of
acute hypoxia in bovine retinal arteries without surrounding
retinal tissue resulted in only a small relaxation, but when
hypoxia was induced in the arteries with surrounding retinal
tissue, it resulted in a large relaxation. Reoxygenation reversed
this relaxation.10 This finding was confirmed on pigs, mice,
and rats.6,7,18,19 Furthermore, it was discovered that direct
contact between the retina and the blood vessel was not
necessary for the hypoxic vasorelaxation, indicating the
involvement of a diffusible factor.10
The potential involvement of different hypoxia-induced
vasorelaxants was tested. NO, COX metabolites, pH, Kþ,
adenosine, and excitatory amino acids (GABA, glutamate,
aspartic acid, glycine, and taurine) could all be excluded.6,10
The hypoxic vasorelaxation was reduced when bovine retinal
arteries were contracted with 120 mM Kþ KRB solution, which
is in line with the RRF being involved in the hypoxic
vasorelaxation. In addition, ATP, or actually the reduction of
ATP, could be involved. Blocking the ATP production with
iodoacetate or sodium cyanide produced a complete relaxa-
tion, which indicated that a reduction of ATP, as occurs during
hypoxia, causes vasodilation.10
Kringelholt et al. reported that the hypoxia-induced
relaxation by surrounding retinal tissue was mediated by
prostaglandins and NO (Fig. 2).19 Nx-Nitro-L-arginine methyl
ester hydrochloride (L-NAME), a NOS inhibitor, could reduce
the hypoxic relaxation, whereas Delaey et al. observed almost
no inhibition by L-NA, also a NOS inhibitor.10,19 Also, other
studies confirmed the finding that NO is involved in the
hypoxic relaxation of retinal arteries.20,21 Furthermore, it was
reported that this relaxation depends on inducible (iNOS)
rather than nNOS, because the iNOS inhibitor 1400W could
FIGURE 1. Overview of the mechanisms involved in the RRF-induced
relaxation. Uncertain connections are represented by dotted lines and
more confirmed connections by solid lines. The RRF may induce
relaxation via activation of PMCA, KV, Kir, and inhibition of Rho kinase,
which then no longer inhibits MLC phosphatase, so MLC-P can be
dephosphorylated resulting in relaxation.
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also inhibit the relaxation, in contrast to the nNOS inhibitor 7-
nitroindazole. The involvement of endothelial NO synthase
(eNOS) could not be excluded.22,23 It has even been suggested
that lactate formed during hypoxia could stimulate NOS and
thus regulate the hypoxic relaxation (Fig. 2).11 However,
previous studies showed that L-lactate, which is released from
retinal glial and neuronal cells during hypoxia, could only
induce a relaxation at high concentrations.10,12,24 On the other
hand, Hein et al. showed that L-lactate was able to produce a
substantial relaxation at physiologic relevant concentrations.11
Furthermore, this lactate-induced relaxation appeared to act
via NOS, guanylyl cyclase, and KATP channel activation (Fig.
2).11,12
Ibuprofen or diclofenac, COX inhibitors, also reduced the
hypoxic relaxation, an observation that does not confirm the
findings of Delaey et al.10,19,22 Interestingly, the lactate-induced
relaxation could also be partially blocked by the COX inhibitor
indomethacin.11 Further investigation showed that the prosta-
glandin E2 receptor 4 (EP4) was involved and not EP1 or EP2
receptors (Fig. 2). Inhibiting iNOS and the EP4 receptor could
not abolish the hypoxia-induced relaxation completely, imply-
ing the involvement of other mechanisms in the hypoxia-
induced relaxation of retinal arteries.23
RETINAL RELAXING FACTOR, ADENOSINE, AND ATP
Besides hypoxia, adenosine-induced relaxations are stronger in
the presence of perivascular retinal tissue.25,26 This suggests
that adenosine might promote the release of the RRF.26
Adenosine is formed by the hydrolysis of ATP, which also
causes a relaxation of retinal arteries that is enhanced by the
retinal tissue.25 Maenhaut et al. reported that the enhancement
of the adenosine-induced relaxation by retinal tissue was larger
than that of the ATP-induced one on bovine retinal arteries,26
whereas Holmgaard et al. saw the opposite on porcine retinal
arterioles, explaining this by ATP-induced ATP release in the
retina.25 This difference might be species related, because
Maenhaut et al. reported that the vasorelaxing effect of
adenosine was enlarged by using rat retina instead of bovine
retina but reduced by using porcine retina instead of bovine
retina.26 The adenosine-induced relaxation was independent of
NOS, COX, and EET synthesis.25,26 It was reduced in presence
of the 120 mM Kþ KRB solution and by using rat carotid
arteries instead of bovine retinal arteries, which is in
accordance with the characteristics of the RRF, suggesting an
involvement of the RRF in the adenosine relaxation.26 It has
been reported that adenosine has both vasocontractile and
vasorelaxing effects on porcine retinal arteries with perivascu-
lar tissue. It induces vasoconstriction by acting on A3 receptors
on the retinal artery and A1 receptors on the perivascular
tissue, whereas it induces relaxation by acting on the A1 and
A2B receptors on the retinal artery and the A2A receptors on the
retinal tissue (Fig. 2).27
The ATP-induced relaxation in the presence of the
perivascular retina is, in contrast to the adenosine-induced
one, mediated by COX, which produces prostaglandin E that
acts on EP1 receptors on the retinal artery. Prostaglandin E is
produced by ATP but not by adenosine.28
NMDA can induce the hydrolysis of ATP to adenosine in the
retina by binding on its NMDA receptor.29 Besides inducing
vasorelaxation via adenosine, NMDA also produces COX
products but not prostaglandin E. It is suggested that the
RRF is related to these pathways (Fig. 2).28
FIGURE 2. Overview of retina-dependent relaxation mechanisms of hypoxia, H2S, adenosine, ATP, NMDA, GABA, and dorzolamide, of which the
relaxation mechanisms may also be related to the RRF. Uncertain connections are represented by dotted lines and more confirmed connections by
solid lines. Hypoxia induces relaxation by activating COX and iNOS (maybe via lactate) in the retina, which leads to the production of PGs from AA
and NO from L-arginine. The PGs bind on the EP4 receptor and NO on sGC, which converts GTP into cGMP, which then activates KATP. Furthermore,
hypoxia-induced relaxation mechanisms may include the RRF, like the H2S-induced relaxation, which may be linked to the hypoxia-induced
relaxation. H2S is formed in the retina by CBS and possibly CSE. Adenosine can induce relaxation by binding on A1 and A2B receptors on smooth
muscle cells or on the A2A receptor in the retina or by the RRF. Furthermore, adenosine can be transformed into ATP, which stimulates COX to
produce PGE that binds on the EP1 receptor. NMDA also activates COX to produce PG, but not PGE, and it causes hydrolysis of ATP to
adenosine. GABA acid binds on the GABAB or GABAC receptor in the retina to induce relaxation, which may act via the RRF. Dorzolamide (a
carbonic anhydrase inhibitor)-induced relaxation might also relax via the RRF, but also stimulates iNOS or nNOS in the retina, resulting in NO
production.
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RETINAL RELAXING FACTOR AND GABA
The GABA-induced relaxation depends on the presence of
perivascular retinal tissue.9,30,31 Hinds et al. proved that GABA
was able to relax rat retinal arteries in the presence but not in
the absence of perivascular retinal tissue.31 Bek et al. showed
similar results, but remarkably GABA was only able to induce
relaxation of porcine retina arterioles when the NMDA
relaxation pathway was inhibited. Furthermore, the GABA-
induced relaxation is mediated via GABAC receptors in porcine
retina,30 whereas the GABAB receptor is involved in rat retina
(Fig. 2).31 This difference may be due to the use of different
contractile substances (U46619 and DL-APV versus endothelin-
1) or the use of different species (porcine versus rat retinal
arterioles). However, the rat retinal arterioles could not
contract with U46619 and DL-APV, in contrast to the porcine
retinal arterioles, indicating that the contradictory results are
due to species differences.31
RETINAL RELAXING FACTOR AND HYDROGEN
SULFIDE
Hydrogen sulfide (H2S) is endogenously synthesized from L-
cysteine by cystathionine b-synthase (CBS) and cystathionine c-
lyase (CSE) in a lot of tissues, including bovine eyes.32 The H2S
donor GYY4137 is able to induce a substantial vasorelaxation
in porcine retinal arterioles and the H2S donor NaHS in porcine
and bovine retinal arteries.18,33 The NaHS-induced relaxation is
reduced in the presence of 100 mM Kþ, just like the RRF-
induced relaxation. Further research revealed that the H2S
relaxation was endothelium, NO, COX, guanylyl cyclase, and
adenylyl cyclase independent, but that Kir and KV channels are
involved. H2S is probably formed by CBS and not by CSE in
bovine retina, because the relaxation induced by L-cysteine
could be blocked by a CBS inhibitor but not by a CSE
inhibitor.33 This is in contrast to the findings on porcine retinal
arterioles where the CBS and CSE blockers both could inhibit
the vasorelaxing influence of L-cysteine. The effect of the CBS
and CSE blockers was larger in the presence of retinal tissue
and during hypoxia. Therefore, it is suggested that H2S partially
mediates the RRF-induced and hypoxia-induced relaxation on
retinal arteries (Fig. 2).18
RETINAL RELAXING FACTOR AND CARBONIC
ANHYDRASE INHIBITORS
Carbonic anhydrases catalyze the association of carbon dioxide
and water to carbonic acid, which dissociates spontaneously
into bicarbonate and hydrogen ions. This reaction can be
catalyzed by carbonic anhydrase in both directions.34 Some
inhibitors of carbonic anhydrases are known to relax bovine
retinal arteries or porcine retinal arterioles.34,35 The relaxing
effect of dorzolamide and acetazolamide, in contrast to methyl
bromopyruvate and ethyl bromopyruvate, is reduced in the
absence of perivascular retinal tissue, indicating that the retina
plays a role in their relaxation.34,36 The relaxation is not due to
inhibition of carbonic anhydrase, and the dorzolamide-induced
relaxation is independent of the acidification in the extracel-
lular and intracellular space of the retinal vascular smooth
muscle cells. The dorzolamide-induced relaxation acts partially
via NO. The origin of NO is as yet unknown, but it might be
produced in the retina by nNOS or iNOS or in the vascular
endothelium by eNOS. However, other factors of the retina
must also be involved in this relaxation, and this might include
the RRF (Fig. 2).37
CELLULAR SOURCE OF THE RRF
Flickering light increases the retinal blood flow, indicating that,
as in the brain, there exists a neurovascular coupling in the
retina. This neurovascular coupling means that when the
neural activity increases, in this case by flickering light, the
higher demand for nutrients and oxygen is compensated by an
increased blood flow through release of retinal vasodila-
tors.38–41 The RRF could be one of these retinal vasodilators.
Vasorelaxing substances can be released from two cell types of
the retina: neurons and glial cells.3 Incubating bovine retina
with tetrodotoxin, which inhibits neuronal activity, had no
effect on the vasorelaxing effect of the retinal tissue, indicating
that the RRF is rather released from retinal glial cells than from
retinal neurons.4 Misfeldt et al. showed that the ATP-induced
relaxation of porcine retinal arterioles, which is retina
dependent, is associated with increased calcium activity in
perivascular cells that are located external to the smooth
muscle cells but internal to the glial cells.42,43 These
perivascular cells are similar to pericytes, and it is known that
pericytes, which are only present on smaller arteries without
vascular smooth muscle cells, regulate the blood flow.44
Further research is needed to find out if these perivascular
cells might be the source of the RRF.
RETINAL RELAXING FACTOR IN RETINAL PATHOLOGY
There is not much known about the RRF in retinal pathology.
Hyperglycemia, the hallmark of diabetes, causes macrovascular
and microvascular damage, also in retinal vessels.45 Agus et al.
tested the retina-derived relaxation on carotid and mesenteric
arteries of streptozotocin-induced diabetic rats. However, the
retina-induced relaxations were similar when using tissues
from diabetic and control animals.46 The retina-derived
relaxations were also evaluated in rats with hypertension
induced by L-NAME, because hypertension also causes vascular
damage in retinal arteries.47,48 The relaxing effect of the RRF
was unaltered by hypertension.47 Furthermore, the influence
of glaucoma, which is characterized by an elevated intraocular
pressure and damage of the optic nerve and surrounding
retinal tissue, was studied on the RRF response.49,50 Glaucoma
conditions were induced by elevating the intraocular pressure
by cauterization of the episcleral veins. The RRF-induced
relaxation was unaltered by glaucoma.49 Thus far, no retinal
pathology has been associated with an altered RRF response.
CONCLUSIONS
It is clear that the retinal tissue plays an important role in the
regulation of the retinal blood flow by releasing relaxing
factors from the retina; one of them might be the so-called RRF.
The identity of the RRF is as yet elusive (Table), as is the
cellular source of the RRF. Its vasorelaxing mechanism is being
elucidated bit by bit: Rho kinase seems to be involved, as well
as Kir channels (Fig. 1). The RRF might also be involved in
vasorelaxation pathways related to hypoxia, adenosine and
ATP, hydrogen sulfide, NMDA, GABA, and dorzolamide (Fig. 2).
Further research is required to reveal the identity and the
mechanism of action of the RRF. This will unmask the
physiologic role of the RRF in the regulation of the retinal
blood flow.
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